Insulet Corp. (PODD)

Insulet to Announce Third Quarter 2026 Financial Results on November 4, 2026

Why Insulet (PODD) is a Top Growth Stock for the Long-Term

Insulet Targets Type 2 Retention as Omnipod 6 and Global Growth Gain Momentum

Insulet Targets Type 2 Retention as Omnipod 6 and Global Growth Gain Momentum

Insulet Corporation (PODD) Presents at Bernstein Insights: Healthcare Leaders and Disruptors - 3rd Annual Healthcare Forum Transcript

Insulet to Participate in Bernstein Insights: Healthcare Leaders and Disruptors – 3rd Annual Healthcare Forum

California State Teachers Retirement System Has $2.22 Billion Stock Position in Insulet Corporation $PODD

Insulet Corporation $PODD Stock Position Raised by Amundi

Insulet Corporation (PODD) Presents at Wells Fargo 21st Annual Healthcare Conference Transcript

Here's Why Insulet (PODD) is a Strong Growth Stock

Is it Prudent to Retain Insulet Stock in Your Portfolio for Now?

Insulet (PODD) is a Top-Ranked Value Stock: Should You Buy?

Why Is Insulet (PODD) Up 8.1% Since Last Earnings Report?

Baron SMID Cap ETF Q2 2026 Portfolio Activity